Skip to content
★ Sign in to follow
ML
Total declarations
17
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (9 ops.)
€3.6M

Latest filing published 02 Dec 2019 for Anaptysbio, INC, €290k.

Filing timeline

BuySale
Marco Londei

Insider track record

Disclosed buys
0
Disclosed sells
9
Signal history

Marco Londei: trading record in brief

This profile gathers the share dealings of Marco Londei in Anaptysbio, Inc. In total, 17 filings cover trades dated from 31 January 2017 to 27 November 2019.

The open-market record consists of 9 sales worth €3.6M, with no purchase. Other entries cover 6 option exercises. So far in 2019, the count stands at no purchases and 5 sales.

The latest filing, published on 2 December 2019, reports an option exercise of €290k in Anaptysbio, Inc. Typically, a trade is published a median of 1 day after it takes place. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Marco Londei

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations17 total
  • ◇
    Chief Medical OfficerExecutivesAnaptysbio, Inc
    320,180 USD12SEC
    46,202 shares@ US$6.936.9% of flowCommon StockSEC:0001209191-19-058549:0
  • ◇
    Chief Medical OfficerExecutivesAnaptysbio, Inc
    7,042 USD11SEC
    10,060 shares@ US$0.700.1% of flowCommon StockSEC:0001209191-19-034870:0
  • ▼
    Chief Medical OfficerExecutivesAnaptysbio, Inc
    435,359 USD12SEC
    6,009 shares@ US$72.45119.2% of flowCommon StockSEC:0001209191-19-034870:1
  • ▼
    Chief Medical OfficerExecutivesAnaptysbio, Inc
    150,384 USD11SEC
    2,048 shares@ US$73.42963.2% of flowCommon StockSEC:0001209191-19-034870:2
  • ▼
    Chief Medical OfficerExecutivesAnaptysbio, Inc
    149,219 USD11SEC
    2,003 shares@ US$74.49783.1% of flowCommon StockSEC:0001209191-19-034870:3
  • ●
    Chief Medical OfficerExecutivesAnaptysbio, Inc
    0SEC
    122,500 shares0Common StockSEC:0001209191-19-003996:0
  • ◇
    Chief Medical OfficerExecutivesAnaptysbio, Inc
    132,190 USD11SEC
    19,075 shares@ US$6.932.7% of flowCommon StockSEC:0001209191-19-003996:1
  • ▼
    Chief Medical OfficerExecutivesAnaptysbio, Inc
    289,701 USD24SEC
    4,181 shares@ US$69.296.0% of flowCommon StockSEC:0001209191-19-003996:2
  • ▼
    Chief Medical OfficerExecutivesAnaptysbio, Inc
    1M USD25SEC
    14,894 shares@ US$70.0421.5% of flowCommon StockSEC:0001209191-19-003996:3
  • ◇
    Chief Medical OfficerExecutivesAnaptysbio, Inc
    5,634 USD11SEC
    8,048 shares@ US$0.700.1% of flowCommon StockSEC:0001209191-18-063384:0
  • ◇
    Chief Medical OfficerExecutivesAnaptysbio, Inc
    152,460 USD11SEC
    22,000 shares@ US$6.933.2% of flowCommon StockSEC:0001209191-18-063384:1
  • ▼
    Chief Medical OfficerExecutivesAnaptysbio, Inc
    792,178 USD28SEC
    12,120 shares@ US$65.361216.6% of flowCommon StockSEC:0001209191-18-063384:2
  • ▼
    Chief Medical OfficerExecutivesAnaptysbio, Inc
    211,416 USD26SEC
    3,185 shares@ US$66.37874.4% of flowCommon StockSEC:0001209191-18-063384:3
  • ▼
    Chief Medical OfficerExecutivesAnaptysbio, Inc
    540,684 USD27SEC
    8,002 shares@ US$67.568611.3% of flowCommon StockSEC:0001209191-18-063384:4
  • ▼
    Chief Medical OfficerExecutivesAnaptysbio, Inc
    461,578 USD27SEC
    6,741 shares@ US$68.47329.7% of flowCommon StockSEC:0001209191-18-063384:5
  • ◇
    Chief Medical OfficerExecutivesAnaptysbio, Inc
    100,000 USD11SEC
    142,857 shares@ US$0.702.0% of flowCommon StockSEC:0001209191-18-050362:0
  • ●
    Chief Medical OfficerExecutivesAnaptysbio, Inc
    0SEC
    2,020 shares0Common StockSEC:0001209191-17-006403:0

17 of 17 declarations